scholarly journals Changes of Multisectoral Collaboration and Service Delivery in Hypertension Prevention and Control before and after the 2009 New Healthcare Reform in China: An Interrupted Time-Series Study

2021 ◽  
Vol 2021 ◽  
pp. 1-9
Author(s):  
Zhifan Zhang ◽  
Zhi Hu ◽  
Hua Wang ◽  
Qingyu Zhou ◽  
Chengyue Li ◽  
...  

Objectives. There is a need to assess the 2009 new healthcare reform in China on hypertension prevention. It helps to control from the perspectives of multisectoral participation, government responsibility assignment, performance assessment, and service delivery. Design. Interrupted time-series study. Setting. 31 provinces in mainland China. Primary and Secondary Outcome Measures. Based on the content analysis of publicly available policy documents from 31 provinces regarding hypertension prevention and control, we analyzed the changes brought by the 2009 new healthcare reform through four quantitative indicators, including multisector participation (MP), main department responsibility coverage (MDRC), primary department assessment indicator coverage (MDAIC), and service type coverage (STC). We compared the changing trends of four indicators before and after 2009. Results. Nationally, MP, MDRC, and STC grew rapidly and increased to 88.9%, 96.4%, and 77.8%, respectively, in 2017, higher than MDAIC (36.9%). This growth was accelerated by the new healthcare reform, with the highest acceleration in MP (β3 = 6.345, p < 0.001 ), followed by MDRC (β3 = 3.829, p < 0.01 ), STC (β3 = 3.799, p < 0.001 ), and MDAIC (β3 = 3.585, p < 0.001 ). The MP and MDRC trend changes were higher in the central and western regions than in the east after the reform. Conclusions. Our research showed that the new healthcare reform had a positive effect in promoting multisectoral participation in preventing and controlling hypertension in China, improving the responsibility mechanism, and expanding the types of services provided. The government should lead the coordination and implementation of multidepartmental responsibilities and mobilize nonhealth departments to continuously participate in the prevention and control of chronic diseases by improving incentive and evaluation mechanisms.

Addiction ◽  
2021 ◽  
Author(s):  
Mark Robinson ◽  
Daniel Mackay ◽  
Lucie Giles ◽  
Jim Lewsey ◽  
Elizabeth Richardson ◽  
...  

2018 ◽  
Vol 67 (6) ◽  
pp. 954-957 ◽  
Author(s):  
Philip W Lam ◽  
Cheryl Volling ◽  
Tiffany Chan ◽  
J Bradley Wiggers ◽  
Lucas Castellani ◽  
...  

2021 ◽  
Vol 125 ◽  
pp. 108449
Author(s):  
Adeline Degremont ◽  
Elisabeth Polard ◽  
Sandrine Kerbrat ◽  
Olivier Grimaud ◽  
Annie-Pierre Jonville-Béra ◽  
...  

2019 ◽  
Vol 19 (1) ◽  
Author(s):  
Fatma Karapinar-Çarkıt ◽  
Sander D. Borgsteede ◽  
Marjo J. A. Janssen ◽  
Marlies Mak ◽  
Nimet Yildirim ◽  
...  

Abstract Background Medication errors at transition of care can adversely affect patient safety. The objective of this study is to determine the effect of a transitional pharmaceutical care program on unplanned rehospitalisations. Methods An interrupted-time-series study was performed, including patients from the Internal Medicine department using at least one prescription drug. The program consisted of medication reconciliation, patient counselling at discharge, and communication to healthcare providers in primary care. The primary outcome was the proportion of patients with an unplanned rehospitalisation within six months post-discharge. Secondary outcomes were drug-related hospital visits, drug-related problems (DRPs), adherence, believes about medication, and patient satisfaction. Interrupted time series analysis was used for the primary outcome and descriptive statistics were performed for the secondary outcomes. Results In total 706 patients were included. At 6 months, the change in trend for unplanned rehospitalisations between usual care and the program group was non-significant (− 0.2, 95% CI -4.9;4.6). There was no significant difference for drug-related visits although visits due to medication reconciliation problems occurred less often (4 usual care versus 1 intervention). Interventions to prevent DRPs were present for all patients in the intervention group (mean: 10 interventions/patient). No effect was seen on adherence and beliefs about medication. Patients were significantly more satisfied with discharge counselling (68.9% usual care vs 87.1% program). Conclusions The transitional pharmaceutical care program showed no effect on unplanned rehospitalisations. This lack of effect is probably because the reason for rehospitalisations are multifactorial while the transitional care program focused on medication. There were less hospital visits due to medication reconciliation problems, but further large scale studies are needed due to the small number of drug-related visits. (Dutch trial register: NTR1519).


2018 ◽  
Vol 23 ◽  
pp. S10
Author(s):  
Gillian Ray-Barruel ◽  
Marie Cooke ◽  
Marion Mitchell ◽  
Vineet Chopra ◽  
Claire Rickard

2016 ◽  
Vol 41 (2) ◽  
pp. 203-208 ◽  
Author(s):  
C. García-Molina Sáez ◽  
E. Urbieta Sanz ◽  
M. Madrigal de Torres ◽  
T. Vicente Vera ◽  
M. D. Pérez Cárceles

Sign in / Sign up

Export Citation Format

Share Document